Generare secures €20M to scale molecular discovery platform

Generare, a Paris-based biotechnology company focused on generating molecular data for drug development, has raised €20 million in a Series A funding round. The round was co-led by Alven and Daphni, with participation from existing investors including Galion.exe, Teampact Ventures, and VIVES Partners.Drug discovery has historically been constrained to a relatively narrow chemical space, largely due to limited data availability beyond it. At the same time, microbial genomes contain a vast…